CANCERX Trademark

Trademark Overview

On Thursday, January 26, 2023, a trademark application was filed for CANCERX with the United States Patent and Trademark Office. The USPTO has given the CANCERX trademark a serial number of 97769370. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 27, 2025. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The CANCERX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing digital consultancy in the field of business management and providing business management services to corporate partners in the field of digital healthcare and health solutions
cancerx

General Information

Serial Number97769370
Word MarkCANCERX
Filing DateThursday, January 26, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements

Pseudo MarkCANCER X
Goods and ServicesProviding digital consultancy in the field of business management and providing business management services to corporate partners in the field of digital healthcare and health solutions

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33612
Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Trademark Events

Event DateEvent Description
Wednesday, September 6, 2023NON-FINAL ACTION WRITTEN
Monday, January 30, 2023NEW APPLICATION ENTERED
Wednesday, February 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Wednesday, September 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 11, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, May 11, 2024OPPOSITION INSTITUTED NO. 999999
Sunday, May 12, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, April 18, 2025OPPOSITION DISMISSED NO. 999999
Tuesday, May 27, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 15, 2025TEAS STATEMENT OF USE RECEIVED
Friday, April 18, 2025OPPOSITION TERMINATED NO. 999999
Friday, April 18, 2025TTAB RELEASE CASE TO TRADEMARKS

Related Keywords

cancerx business providing field management digital health solutions healthcare corporate services